Penetrance of familial hypertrophic cardiomyopathy

被引:0
|
作者
Charron, P
Carrier, L
Dubourg, O
Tesson, F
Desnos, M
Richard, P
Bonne, G
Guicheney, P
Hainque, B
Bouhour, JB
Mallet, A
Feingold, J
Schwartz, K
Komajda, M
机构
[1] HOP LA PITIE SALPETRIERE,SERV CARDIOL,F-75651 PARIS 13,FRANCE
[2] HOP LA PITIE SALPETRIERE,INSERM U153,F-75651 PARIS 13,FRANCE
[3] HOP LA PITIE SALPETRIERE,SERV BIOCHIM,F-75651 PARIS 13,FRANCE
[4] HOP AMBROISE PARE,SERV CARDIOL,BOULOGNE,FRANCE
[5] HOP BOUCICAULT,SERV CARDIOL,PARIS,FRANCE
[6] HOP LAENNEC,SERV CARDIOL,NANTES,FRANCE
[7] INSERM U436,PARIS,FRANCE
[8] INSERM U155,UNITE RECH EPIDEMIOL GENET,PARIS,FRANCE
来源
GENETIC COUNSELING | 1997年 / 8卷 / 02期
关键词
hypertrophic cardiomyopathy; penetrance; genetic counseling; linkage analysis;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Familial hypertrophic cardiomyopathy (FHC) is an autosomal dominant cardiac disease for which the penetrance remains a much-debated issue. Since the recent identification of the genes involved in the disease, the penetrance of FHC has not been reassessed in a large genotyped population. The aim of our study was therefore to evaluate it, according to age and sex, in ten families with previously identified mutations. Among 178 individuals we studied, 90 were genetically affected (9 different mutations in 3 genes). We found that penetrance, assessed by classical echocardiographic and electrocardiographic criteria, was (1) incomplete: 69%; (2) age-related: 55% between 10 and 29 years old, 75% between 30 and 49 y. and 95% over 50 y.; (3) greater in males than in females: 77% vs 58%, age-adjusted odds ratio: 3.98, CI 95%: 1.34 to 11.48; (4) similar for the genes analyzed. The consequences of these results for genetic counseling and linkage analyses are discussed.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 50 条
  • [1] FAMILIAL HYPERTROPHIC CARDIOMYOPATHY
    OAKLEY, C
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1972, 48 (566) : 724 - 727
  • [2] Familial hypertrophic cardiomyopathy
    Vujin, Bojan
    Benc, Dragan
    Sirdic, Svetozar
    Vuckovic, Dejan
    Radisic, Biljana
    Kovac, Marko
    [J]. HERZ, 2007, 32 (02) : 172 - 174
  • [3] Familial Hypertrophic Cardiomyopathy
    Bojan Vujin
    Dragan Benc
    Svetozar Srdic
    Dejan Vučkovic
    Biljana Radisic
    Marko Kovac
    [J]. Herz Kardiovaskuläre Erkrankungen, 2007, 32 : 172 - 174
  • [4] FAMILIAL HYPERTROPHIC CARDIOMYOPATHY
    MCCULLAGH, P
    GALLAGHER, PJ
    [J]. JOURNAL OF PATHOLOGY, 1993, 169 (03): : 289 - 290
  • [5] FAMILIAL HYPERTROPHIC CARDIOMYOPATHY
    ROZENBERG, VD
    [J]. ARKHIV PATOLOGII, 1991, 53 (04) : 62 - 64
  • [6] Familial hypertrophic cardiomyopathy
    Apetrei, E
    Rugina, M
    Stoian, I
    Alexandru, D
    [J]. XIII WORLD CONGRESS OF CARDIOLOGY: FREE PAPERS, 1998, : 653 - 659
  • [7] FAMILIAL APICAL HYPERTROPHIC CARDIOMYOPATHY
    PENAS, M
    FUSTER, M
    FABREGAS, R
    LLORENTE, C
    COSIO, FG
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (10): : 821 - 822
  • [8] FAMILIAL NEUROFIBROMATOSIS AND HYPERTROPHIC CARDIOMYOPATHY
    FITZPATRICK, AP
    EMANUEL, RW
    [J]. BRITISH HEART JOURNAL, 1988, 60 (03): : 247 - 251
  • [9] FAMILIAL HYPERTROPHIC CARDIOMYOPATHY AND PREEXCITATION
    HAUSER, AM
    GORDON, S
    TIMMIS, GC
    [J]. AMERICAN HEART JOURNAL, 1984, 107 (01) : 176 - 179
  • [10] FAMILIAL HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    HEINZE, W
    MINAMI, K
    FASSBENDER, D
    KORFER, R
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 113 (10) : 381 - 383